FE
57
2
VZ
54
4
WY
60
7
WBA
29
2
FRT
63
10
GE
82
5
AAPL
40
-2
MLM
50
3
HBI
62
4
ALL
66
2
NWS
37
2
NAVI
55
15
VRSK
56
16
FLR
48
6
ROK
47
3
VRTX
62
5
STX
59
6
EBAY
50
-2
KR
52
2
AMG
38
2
FE
57
2
VZ
54
4
WY
60
7
WBA
29
2
FRT
63
10
GE
82
5
AAPL
40
-2
MLM
50
3
HBI
62
4
ALL
66
2
NWS
37
2
NAVI
55
15
VRSK
56
16
FLR
48
6
ROK
47
3
VRTX
62
5
STX
59
6
EBAY
50
-2
KR
52
2
AMG
38
2
Financhill
Back

Ascendis Pharma AS Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
19

ASND
Ascendis Pharma AS

Last Price:
119.23
Seasonality Move:
6.19%
Sell
25

ALNY
Alnylam Pharmaceuticals

Last Price:
265.13
Seasonality Move:
5.61%
Sell
19
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $119.22. The Score for ASND is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $265.27. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $119.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $265.27
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.22 Sell
Relative Strength Index (14 RSI): 36.71 Sell
Chaikin Money Flow: 513202 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.69 - 140.77) Sell
Bollinger Bands (100): (125.49 - 139.43) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 53.6 Buy
Chaikin Money Flow: 403934 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (256.2 - 277.22) Sell
Bollinger Bands (100): (158.9 - 265.08) Buy

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.93 Buy
20-day SMA: 129.69 Sell
50-day SMA: 132.39 Sell
200-day SMA: 134.63 Sell
8-day EMA: 119.25 Sell
20-day EMA: 125.59 Sell
50-day EMA: 130.26 Sell
200-day EMA: 128.97 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 256.17 Buy
20-day SMA: 266.77 Sell
50-day SMA: 258.27 Buy
200-day SMA: 189.51 Buy
8-day EMA: 260.57 Buy
20-day EMA: 261.96 Buy
50-day EMA: 250.03 Buy
200-day EMA: 205.35 Buy

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.79 per share, an increase next quarter of $1.47 per share, an increase this year of $1.68 per share, and an increase next year of $4.41 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):